Skip to main content

Table 2 Antibiotic resistance patterns in E. faecalis isolates form urine and fecal specimens inpatients with community acquired-UTIs

From: Genetic relatedness of the Enterococcus faecalis isolates in stool and urine samples of patients with community-acquired urinary tract infection

Antibiotic resistance patternsa Urine samples
N = 63 (%)
Fecal samples
N = 63 (%)
Same resistance patternsb
TET, MIN, GM120, CP, LEV, GAT 5 (7.9%) 2 (3.1%) 2
TET, MN, GM120, CP 2 (3.1%) 0 (0%) 0
TET, MN, GM120 10 (15.8%) 8 (12.6%) 7
TET, MN, CP, LEV, GAT 3 (4.7%) 0 (0%) 0
TET, MN, CP, GAT 0 (0%) 1 (1.5%) 0
TET, MN, CP, LEV 0 (0%) 1 (1.5%) 0
TET, CP, LEV, GAT 0 (0%) 1 (1.5%) 0
TET, MN, CP 2 (3.1%) 2 (3.1%) 1
TET, MN 33 (52.3%) 31 (49.2%) 25
CP, LEV 1 (1.5%) 0 (0%) 0
TET 1 (1.5%) 2 (3.1%) 1
GM120 1 (1.5%) 0 (0%) 0
No resistance 4 (6.3%) 15 (23.8%) 3
  1. aTET, tetracycline; MIN, minocycline; GM120, gentamicin 120 µg; CP, ciprofloxacin; LEV, levofloxacin; GAT, gatifloxacin. Resistance phenotypes were determined for all antibiotics, except daptomycin, by disk diffusion (Kirby–Bauer) method according to CLSI 2014 guidelines (MastGroupLtd, United Kingdom). Antibiotic concentration for each disk was as follows: Penicillin G (10 units), ampicillin (10 µg), vancomycin (30 µg), tetracycline (30 µg), minocycline (30 µg), ciprofloxacin (5 µg), levofloxacin (5 µg), gatifloxacin (5 µg), nitrofurantoin (300 µg), high level gentamicin-resistant enterococci (HLGRE, 120 µg) and linezolid (30 µg)
  2. bPatients with similar resistance patterns in both fecal and urine samples